Evidence for use of glatiramer acetate in multiple sclerosis.
Caramanos
Zografos
Z
Magnetic Resonance Spectroscopy Unit, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Arnold
Douglas L
DL
D000068717:Glatiramer Acetate; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015201:Meta-Analysis as Topic; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010455:Peptides / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D010455:Peptides; D000068717:Glatiramer Acetate